Medindia

X

ChromaDex Reports Financial Results for the First Quarter 2011

Thursday, May 12, 2011 General News J E 4
Advertisement
Highlights include a 31% increase in revenue compared to first quarter 2010 and positive cash flow in the quarter

Condensed Consolidated Statements of Operations

Excluding Share-based Compensation (Non-GAAP Presentation)

Three Months Ended

April 2, 2011

April 3, 2010

Sales

$             2,539,245

$                      1,937,592

Cost of sales

1,518,850

1,119,619

Gross profit

1,020,395

817,973

Operating expenses:

Sales and marketing

445,507

224,619

General and administrative

985,815

502,434

1,431,322

727,053

Operating (loss) income

(410,927)

90,920

Nonoperating (income) expenses:

Interest expense

8,873

5,699

Interest income

(434)

(120)

8,439

5,579

Net (loss) income

$               (419,366)

$                          85,341

Basic and Diluted

 (loss) income per common share

$                    (0.01)

$                              0.00

Basic and Diluted

  average common shares outstanding

62,944,298

28,838,216

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
United Spinal Association Broadens Its Reach with ...
S
Tibet Pharmaceuticals to Host First Quarter 2011 E...